CLVLY Company Profile and Key Details

Q: Who are the executives of CLVLY?

Mr. Darren M. KeamyChief Financial Officer & Company Sec.Mr. Malcolm BullHead of Investor RelationsMr. Lachlan HayDirector of Global OperationsDr. Dennis J. WrightChief Scientific OfficerDr. Philippe Jacques Wolgen M.B.A., M.D., MBAChief Executive Officer, MD & Director

OTC : CLVLY

Clinuvel Pharmaceuticals

$6.70

Open: 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Clinuvel Pharmaceuticals Limited (CLVLY) stock remained unchanged at $6.70 a share on OTC. The stock opened at $6.31, fluctuating between $6.31 to $6.70 during the session.

Stock Snapshot

6.7

Prev. Close

337.75M

Market Cap

6.31

Day Low

14.57

P/E Ratio

0.46

EPS (TTM)

0.72

Cash Flow per Share

6.31

Open

50.41M

Number of Shares

6.7

Day High

82.77%

Free Float in %

3.56

Book Value

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 30, 2026	7.09	7.09	6.70	6.70	6.4K
Apr 29, 2026	6.79	6.79	6.79	6.79	504
Apr 28, 2026	7.05	7.05	7.05	7.05	1
Apr 27, 2026	6.63	6.63	6.63	6.63	257
Apr 23, 2026	6.55	6.55	6.55	6.55	155
Apr 22, 2026	6.17	6.35	6.17	6.35	3.83K
Apr 21, 2026	6.67	6.67	6.63	6.63	288
Apr 20, 2026	6.32	6.32	6.32	6.32	111
Apr 17, 2026	7.00	7.00	7.00	7.00	200
Apr 16, 2026	6.53	6.53	6.53	6.53	600
Apr 14, 2026	7.05	7.05	7.05	7.05	69
Apr 13, 2026	6.11	6.53	6.11	6.53	10.1K
Apr 10, 2026	6.30	6.30	6.30	6.30	303
Apr 09, 2026	6.74	6.74	6.74	6.74	151
Apr 08, 2026	6.60	6.60	6.55	6.60	1.68K
Apr 06, 2026	6.44	6.48	6.30	6.48	3.72K
Apr 02, 2026	6.85	6.85	6.42	6.56	837
Mar 31, 2026	7.24	7.24	7.24	7.24	213
Mar 30, 2026	6.50	6.55	6.50	6.55	7.25K
Mar 27, 2026	7.10	7.10	7.10	7.10	1

Contact Details

Melbourne, VIC 3000

Australia

https://www.clinuvel.com 613 966 04900

About Company

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), which provoke increased and prolonged cellular activity; and PR�NUMBRA, a liquid injectable formulation of afamelanotide. Clinuvel Pharmaceuticals Limited has a collaboration agreement with HK Winhealth Pharma Group Co. Limited t to treat EPP patients with SCENESSE under a named patient program in the People's Republic of China. The company was founded in 1987 and is headquartered in Melbourne, Australia.

Stock Peers

ODTC

Odonate Therapeutics, Inc.$2,849.50 GNMSF

Genmab A/S$268.61 CMXHF

CSL Limited$192.00 NONOF

Novo Nordisk A/S$144.95 CSLLY

0.75+0.79%

CSL Limited$95.35 UCBJY

-0.06-0.08%

UCB SA$73.15 PHMMF

4.3+16.01%

Pharma Mar, S.A.$31.15 BVNKF

Bavarian Nordic A/S$21.20 NURPF

Neuren Pharmaceuticals Limited$14.00 TLPPF

Telix Pharmaceuticals Limited$11.00

Frequently Asked Questions

What is the current Clinuvel Pharmaceuticals Limited (CLVLY) stock price?

Clinuvel Pharmaceuticals Limited (OTC: CLVLY) stock price is $6.70 in the last trading session. During the trading session, CLVLY stock reached the peak price of $6.70 while $6.31 was the lowest point it dropped to. The percentage change in CLVLY stock occurred in the recent session was 0% while the dollar amount for the price change in CLVLY stock was $0.00.

CLVLY's industry and sector of operation?

The OTC listed CLVLY is part of Biotechnology industry that operates in the broader Healthcare sector. Clinuvel Pharmaceuticals Limited designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CLVLY?

Mr. Darren M. Keamy
Chief Financial Officer & Company Sec.
Mr. Malcolm Bull
Head of Investor Relations
Mr. Lachlan Hay
Director of Global Operations
Dr. Dennis J. Wright
Chief Scientific Officer
Dr. Philippe Jacques Wolgen M.B.A., M.D., MBA
Chief Executive Officer, MD & Director

How CLVLY did perform over past 52-week?

CLVLY's closing price is 14.64% higher than its 52-week low of $6.00 where as its distance from 52-week high of $9.00 is -27.75%.

How many employees does CLVLY have?

Number of CLVLY employees currently stands at 0.

Link for CLVLY official website?

Official Website of CLVLY is: https://www.clinuvel.com

How do I contact CLVLY?

CLVLY could be contacted at phone 613 966 04900 and can also be accessed through its website. CLVLY operates from 535 Bourke Street, Melbourne, VIC 3000, Australia.

How many shares of CLVLY are traded daily?

CLVLY stock volume for the day was 1 shares. The average number of CLVLY shares traded daily for last 3 months was 2.13K.

What is the market cap of CLVLY currently?

The market value of CLVLY currently stands at $337.75M with its latest stock price at $6.70 and 50.41M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	0
Beta	0.76
Sales or Revenue	$95.02M
5Y Sales Change%	1.87%
Fiscal Year Ends	June
Sector	Healthcare
Industry	Biotechnology

Employees	0
Beta	0.76
Sales or Revenue	$95.02M
5Y Sales Change%	1.87%
Fiscal Year Ends	June
Sector	Healthcare
Industry	Biotechnology

CLVLY Company Profile and Key Details

Clinuvel Pharmaceuticals

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook